Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib.

PeerJ · 2020 · PMC7668202 · PMID 33240675

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

However, the benefit of OS was marginally significant in the hepatectomy group than in the non-hepatectomy group.

also in 26,082 other papers

may not be significantno p-value reported

Third, the follow-up period may not be adequately long, and some survival benefit may not be significant.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.